Tracy Rose, MD, MPH, Matthew Milowsky, MD, and colleagues report that the regimen reduced the invasiveness of the cancer in 56% of patients in a phase II clinical trial.

Urologic oncologist Angela Smith, MD, MS, has a natural curiosity that inspires her to seek personal insights and ways to improve the lives of those around her.

Angela Smith, MD, MS, FACS, is one of four recipients of the prize, which is awarded to faculty members who exemplify groundbreaking and innovative research.